Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)

Completed · Phase 2

Conditions studied: Obsessive-Compulsive Disorder

In brief

This study investigates if a single dose of IV Ketamine can rapidly improve Obsessive-Compulsive Disorder (OCD) symptoms and whether these effect can be maintained with a condensed course of a type of Cognitive Behavioral Therapy called Exposure and Response Prevention (EX/RP). You will be compensated for your time and travel. Participants must be between the ages of 18-55.

Key facts

Study ID
NCT02062658
Run by
New York State Psychiatric Institute
People needed
10
Starts
2013-12-01
Expected to finish
2015-12-01
Last updated by the study team
2016-12-29

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.